NAD+ is the essential cofactor that allows sirtuins — SIRT1 through SIRT7 — to function. Sirtuins regulate cellular housekeeping processes: DNA repair, mitochondrial biogenesis, inflammation resolution, and metabolic adaptation. When NAD+ is abundant, sirtuins are active and cellular maintenance is

Why NAD+ Matters for Ageing

NAD+ is the essential cofactor that allows sirtuins — SIRT1 through SIRT7 — to function. Sirtuins regulate cellular housekeeping processes: DNA repair, mitochondrial biogenesis, inflammation resolution, and metabolic adaptation. When NAD+ is abundant, sirtuins are active and cellular maintenance is efficient. When NAD+ declines with age, sirtuin activity falls and these maintenance processes become less efficient. The result is accumulating DNA damage, mitochondrial dysfunction, and chronic low-grade inflammation — the hallmarks of biological ageing that appear in virtually every tissue and organ system in the body.

Animal studies have shown unambiguously that raising NAD+ levels extends lifespan in multiple organisms — mice, rats, worms, and flies. Whether the same effect translates to humans is the multi-billion dollar question that the supplement industry is simultaneously trying to answer and profit from. The honest answer is that long-term human lifespan data does not exist yet. What exists is a plausible mechanism, strong animal data, and early-phase human safety and biomarker data that are promising but not conclusive. This is not a reason to dismiss NAD+ precursor supplementation, but it is a reason to maintain realistic expectations about what the current evidence actually demonstrates.

NR: The Earlier and More Established Evidence Base

Nicotinamide riboside was the first NAD+ precursor to be studied extensively in humans. It converts to NAD+ via the Nrk pathway, which is present in most tissues. Human trials have shown that NR supplementation at 250-500mg daily raises blood NAD+ levels measurably, is well-tolerated, and produces improvements in insulin sensitivity and blood pressure in older adults with metabolic impairment. The landmark 2016 study in Nature Communications showed that NR supplementation activated sirtuin-regulated gene expression in skeletal muscle of older men — a finding that directly demonstrated that NR was having the intended biochemical effect in humans, not just raising NAD+ levels as a biomarker.

NR has the longer safety track record in humans. The compound is structurally simple and has been tested in multiple Phase I safety trials with consistent results: well-tolerated, oral bioavailability adequate for NAD+ elevation, no significant adverse events at doses up to 1000mg daily. Both NMN and NR have now been studied in multiple Phase I and Phase II human trials: both raise NAD+ levels in blood, both are well-tolerated at recommended doses, neither has shown significant adverse effects in short-to-medium-term use. The safety profile is encouraging. The caveat is that we simply have not been studying these compounds long enough to know what 20 years of daily use looks like, and that honest uncertainty should accompany any recommendation.

NMN: Newer Data, Similar Safety Profile

NMN has gained more attention in longevity circles despite having less human data than NR, partly because it sits one step closer to NAD+ in the conversion pathway and partly because of high-profile research in mice showing dramatic improvements in muscle insulin sensitivity, mitochondrial function, and physical endurance. Whether these effects translate fully to humans is the critical question that the field is working to answer. The mouse data is genuinely impressive and covers multiple organ systems; the human data is more modest in scope but consistently shows NAD+ elevation as a reliable biomarker of supplementation.

Human trials of NMN are more limited but growing. A 2021 study showed that NMN supplementation at 250mg daily improved physical performance in recreational athletes. More recent trials in older adults have shown improvements in NAD+ biomarkers and some measures of metabolic health. One practical consideration often overlooked in the NMN vs NR debate is stability: NMN is structurally less stable than NR and degrades more readily in storage, particularly at higher temperatures and in humid conditions. A fresh, properly stored NR supplement may deliver more consistent NAD+ precursor than an NMN supplement that has been sitting in a warm warehouse or transported in summer heat.

MetaboDrop and the NAD+ Precursor Question

MetaboDrop combines NAD+ precursor support with other cellular energy compounds. Both NMN and NR have merit as supplements, and the honest answer to which is better is that the evidence has not definitively resolved the question. NR has more human data accumulated over a longer research history; NMN has some mechanistic advantages in conversion efficiency in certain tissues. Both are meaningfully superior to nicotinamide (the cheapest NAD+ precursor) because they bypass the negative feedback on the NAD+ biosynthesis pathway that nicotinamide creates. Nicotinamide can actually suppress NAD+ production through a feedback inhibition mechanism that neither NMN nor NR triggers.